Beranda › Overdosis Opioid › Minnesota
Uji klinis Overdosis Opioid di Minnesota
8 studi untuk Overdosis Opioid mencari peserta di lokasi di Minnesota.
Kota di Minnesota
Teks studi resmi (Bahasa Inggris)
Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses
- Harm Reduction Sisters, Duluth
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07631598Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder
- Hazelden Betty Ford Foundation, Center City
Menerima pesertaStudi observasional
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06487533Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
- Clinic Site C (blinded pending tribal approval), Minneapolis
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06565416Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.
- Hennepin Healthcare Addiction Medicine, Minneapolis
Menerima pesertaFase 4
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06323824Using Facebook to Support Opioid Recovery Among American Indian Women
- Mayo Clinic, Rochester
Menerima peserta
Usia 18 ke atas · Wanita · Diperbarui 4 Sep 2026 · NCT05995886EMS-Initiated Buprenorphine
- Hennepin Healthcare, Minneapolis
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07475728Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder
- University of Minnesota, Minneapolis
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT07158853Brain Training for Substance Use Disorders
- University of Minnesota - Department of Psychiatry & Behavioral Health, Minneapolis
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 11 Mar 2025 · NCT06870110Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.